|
December 19, 2017 0:24 - FDA approves Rhopressa® (netarsudil ophthalmic solution) 0.02% for the lowering of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension http://www.nasdaq.com/press-release/aerie-pharmaceuticals-announces-us-fda-approval-of-rhopressa-netarsudil-ophthalmic-solution-002-fo-20171218-00944 1:35 - FDA approves Ortho Clinical Diagnostics VITROS® Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator on the VITROS® 3600 Immunodiagnostic System https://www.orthoclinical.com/en-us/news-events/news/detailnews?id=c08b6928-c7de-4beb-ba1e-81e625945760 3:34 - FDA proposes new, risk-based enforcement priorities to protect consumers from potentially harmful, unproven homeopathic drugs https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm589243.htm NASCENT MEDICAL Nascent Medical, LLC, has a team of over 100 PhD-/MD-level writers who can write about any medical, scientific or technical topic. They do the following types of writing, including but not limited to: -Video and virtual reality script writing -eLearning scripts -Medical education -Webinar slide creation -Manuscripts -Slidesets -Manuscripts -Press releases -Blog posts -Annual reports -Proposals -White papers -Web content -Posters -Sales training materials contact info@nascentmc.com == First episode of AI in medicine is coming out on Wednesday January 4th, 2018. I will be talking with Dr. Alex Zhavoronkov who is the is the CEO of InSilico Medicine, Inc a company utilizing big data analysis for aging research. https://itunes.apple.com/us/podcast/aimedicines-podcast/id1325232000?mt=2 The episode after that, I’ll be talking with Dawn Laney and Dave Jacob founders of ThinkGenetic.com a company uses artificial intelligence (AI) solutions to improve the speed to diagnosis. Then I will be covering Precision Medicine World conference taking place in Jan 2018 in Silicon Valley. PMWCINTL.com |